News
Teleflex (NYSE: TFX) announced that it received FDA 510(k) clearance for expanded indications of its QuikClot Control+ hemostatic device.
The global wound care market size is anticipated to reach USD 29.57 billion by 2030 and is expected to expand at a CAGR of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback